KDM5C and glioblastoma: Very importantly, the finding that GBM samples (TCGA) with high levels of KDM5C display DNA methylation changes mainly affecting genes involved in the hypoxia response, stem cell differentiation, inflammation, and p53 signaling further corroborates the role of KDM5C in GBM etiology and/or progression.